Studies on antioxidants: their carcinogenic and modifying effects on chemical carcinogenesis.

[1]  S. Fukushima,et al.  Modification by antioxidants and p,p'-diaminodiphenylmethane of 7,12-dimethylbenz[a]anthracene-induced carcinogenesis of the mammary gland and ear duct in CD rats. , 1986, Carcinogenesis.

[2]  M. Hirose,et al.  Combined effects of butylated hydroxyanisole and other antioxidants in induction of forestomach lesions in rats. , 1986, Cancer letters.

[3]  M. Tatematsu,et al.  Relative merits of immunohistochemical demonstrations of placental, A, B and C forms of glutathione S-transferase and histochemical demonstration of gamma-glutamyl transferase as markers of altered foci during liver carcinogenesis in rats. , 1985, Carcinogenesis.

[4]  G. Ansari,et al.  Tissue distribution and pharmacokinetics of 3-t-[methyl-14C] butyl-4-hydroxyanisole in rats. , 1985, Drug metabolism and disposition: the biological fate of chemicals.

[5]  M. Tatematsu,et al.  Dose-dependent effects of butylated hydroxyanisole, butylated hydroxytoluene and ethoxyquin in induction of foci of rat liver cells containing the placental form of glutathione S-transferase. , 1985, Cancer letters.

[6]  K. Sato,et al.  Purification, induction, and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[7]  L. Wattenberg,et al.  Metabolism of 3-tert-butyl-4-hydroxyanisole to 3-tert-butyl-4,5-dihydroxyanisole by rat liver microsomes. , 1985, Cancer research.

[8]  M. Hirose,et al.  Modification by five antioxidants of 1,2-dimethylhydrazine-initiated colon carcinogenesis in F344 rats. , 1985, Carcinogenesis.

[9]  E. Nera,et al.  An 85-day study of butylated hydroxyanisole in the cynomolgus monkey. , 1985, Cancer letters.

[10]  S. Fukushima,et al.  Promoting activities of butylated hydroxyanisole, butylated hydroxytoluene and sodium L-ascorbate on forestomach and urinary bladder carcinogenesis initiated with methylnitrosourea in F344 male rats. , 1984, Gan.

[11]  T Sofuni,et al.  Primary mutagenicity screening of food additives currently used in Japan. , 1984, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[12]  N. Major,et al.  Inhibition of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinogenesis by concomitant or postcarcinogen antioxidant exposure. , 1984, Cancer research.

[13]  S. Fukushima,et al.  Induction of forestomach hyperplasia by crude butylated hydroxyanisole, a mixture of 3-tert and 2-tert isomers, in Syrian golden hamsters is due to 3-tert-butylated hydroxyanisole. , 1984, Gan.

[14]  T. Ishikawa,et al.  Changes in molecular forms of rat hepatic glutathione S-transferase during chemical hepatocarcinogenesis. , 1984, Cancer research.

[15]  S. Fukushima,et al.  Promotion by ascorbic acid, sodium erythorbate and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybutyl) nitrosamine. , 1984, Cancer letters.

[16]  S. Fukushima,et al.  Effects of butylated hydroxyanisole, butylated hydroxytoluene, and NaCl on gastric carcinogenesis initiated with N-methyl-N'-nitro-N-nitrosoguanidine in F344 rats. , 1984, Journal of the National Cancer Institute.

[17]  K. Imaida,et al.  Modifying effects of butylated hydroxyanisole, ethoxyquin and acetaminophen on induction of neoplastic lesions in rat liver and kidney initiated by N-ethyl-N-hydroxyethylnitrosamine. , 1984, Carcinogenesis.

[18]  G. Williams,et al.  Dose-dependent reduction of N-2-fluorenylacetamide-induced liver cancer and enhancement of bladder cancer in rats by butylated hydroxytoluene. , 1984, Cancer research.

[19]  M. Tatematsu,et al.  The placental form of glutathione S-transferase as a new marker protein for preneoplasia in rat chemical hepatocarcinogenesis. , 1984, Gan.

[20]  L. Della Corte,et al.  2,2'-dihydroxy-3,3'-di-t-butyl-5,5'-dimethoxydiphenyl, a new metabolite of 2-t-butyl-4-methoxyphenol in the rat. , 1983, Drug metabolism and disposition: the biological fate of chemicals.

[21]  R. Prough,et al.  Butylated hydroxyanisole-stimulated NADPH oxidase activity in rat liver microsomal fractions. , 1983, The Journal of biological chemistry.

[22]  S. Fukushima,et al.  Promoting effects of sodium L-ascorbate on two-stage urinary bladder carcinogenesis in rats. , 1983, Cancer research.

[23]  A. Rahimtula.  In vitro metabolism of 3-t-butyl-4-hydroxyanisole and its irreversible binding to proteins. , 1983, Chemico-biological interactions.

[24]  S. Fukushima,et al.  Carcinogenicity of butylated hydroxyanisole in F344 rats. , 1983, Journal of the National Cancer Institute.

[25]  H. Heine,et al.  Comparative effects of dietary administration of 2(3)-tert-butyl-4-hydroxyanisole and 3,5-di-tert-butyl-4-hydroxytoluene on several hepatic enzyme activities in mice and rats. , 1982, Cancer research.

[26]  S. Kosanke,et al.  Comparison of the effect of butylated hydroxytoluene on N-nitrosomethylurea and 7,12-dimethylbenz[a]-anthracene-induced mammary tumors. , 1981, Cancer letters.

[27]  P. Talalay,et al.  Elevation of extrahepatic glutathione S-transferase and epoxide hydratase activities by 2(3)-tert-butyl-4-hydroxyanisole. , 1979, Cancer research.

[28]  L. Wattenberg,et al.  Inhibitory effects of butylated hydroxyanisole on methylazoxymethanol acetate-induced neoplasia of the large intestine and on nicotinamide adenine dinucleotide-dependent alcohol dehydrogenase activity in mice. , 1979, Journal of the National Cancer Institute.

[29]  D. Jerina,et al.  Neoplastic effects of oral administration of (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene and their inhibition by butylated hydroxyanisole. , 1979, Journal of the National Cancer Institute.

[30]  P. Talalay,et al.  Elevation of hepatic glutathione S-transferase activities and protection against mutagenic metabolites of benzo(a)pyrene by dietary antioxidants. , 1978, Cancer research.

[31]  F. Martz,et al.  Enhancement of liver microsome epoxide hydratase activity in rodents by treatment with 2(3)-tert-butyl-4-hydroxyanisole. , 1978, Cancer research.

[32]  P. Borchert,et al.  Inhibitors of colon carcinogenesis , 1977 .

[33]  L. Wattenberg,et al.  Effects of butylated hydroxyanisole on the metabolism of benzo[a]pyrene by mouse liver microsomes. , 1977, Journal of the National Cancer Institute.

[34]  B. E. Walker,et al.  Modification of paracetamol toxicity by antioxidants. , 1976, Biochemical Society transactions.

[35]  A L Branen,et al.  Toxicology and biochemistry of butylated hydroxyanisole and butylated hydroxytoluene , 1975, Journal of the American Oil Chemists' Society.

[36]  L. Wattenberg,et al.  Inhibition of chemical carcinogen-induced pulmonary neoplasia by butylated hydroxyanisole. , 1973, Journal of the National Cancer Institute.

[37]  L. Wattenberg.  Inhibition of carcinogenic and toxic effects of polycyclic hydrocarbons by phenolic antioxidants and ethoxyquin. , 1972, Journal of the National Cancer Institute.

[38]  R. Kohn.  Effect of antioxidants on life-span of C57BL mice. , 1971, Journal of gerontology.

[39]  J. K. Ashton,et al.  Tests on mice for evaluating carcinogenicity , 1966 .

[40]  E. A. Maynard,et al.  CHRONIC FEEDING STUDIES OF BUTYLATED HYDROXYANISOLE IN DOGS. , 1964, Toxicology and applied pharmacology.

[41]  K. Ingold.  Inhibition of the Autoxidation of Organic Substances in the Liquid Phase. , 1961 .

[42]  O. H. Wilder,et al.  Food Additives, Safety, Effect of Feeding Butylated Hydroxyanisole to Dogs , 1960 .

[43]  M. Hirose,et al.  Comparison of the effects of 13 phenolic compounds in induction of proliferative lesions of the forestomach and increase in the labelling indices of the glandular stomach and urinary bladder epithelium of Syrian golden hamsters. , 1986, Carcinogenesis.

[44]  M. Hirose,et al.  Histologic and autoradiographic studies on the forestomach of hamsters treated with 2-tert-butylated hydroxyanisole, 3-tert-butylated hydroxyanisole, crude butylated hydroxyanisole, or butylated hydroxytoluene. , 1986, Journal of the National Cancer Institute.

[45]  S. Fukushima,et al.  Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of gamma-glutamyl transpeptidase-positive foci development in the liver of rats. , 1983, Carcinogenesis.

[46]  H. Witschi.  Enhancement of tumor formation in mouse lung by dietary butylated hydroxytoluene. , 1981, Toxicology.

[47]  R. Baker,et al.  Mutagenicity testing of some approved food additives with the Salmonella/microsome assay. , 1980 .

[48]  L. Wattenberg.  Inhibitors of chemical carcinogenesis. , 1978, Advances in cancer research.

[49]  L W Wattenberg,et al.  Inhibition of chemical carcinogenesis. , 1978, Journal of the National Cancer Institute.

[50]  R. Evarts,et al.  Inhibitory effect of butylated hydroxytoluene (BHT) on intestinal carcinogenesis in rats by azoxymethane. , 1977, Food and cosmetics toxicology.

[51]  J. Allen.  Long-term antioxidant exposure effects on female primates. , 1976, Archives of environmental health.